$1.26 Billion is the total value of Woodford Investment Management Ltd's 25 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 10.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TBPH | Buy | THERAVANCE BIOPHARMA INC | $382,071,000 | +50.2% | 11,694,879 | +4.3% | 30.43% | -1.3% |
| AUTL | Buy | AUTOLUS THERAPEUTICS PLCspon ads | $332,030,000 | +678.6% | 10,825,919 | +580.1% | 26.44% | +411.4% |
| PRTA | PROTHENA CORP PLC | $155,974,000 | -10.3% | 11,924,614 | 0.0% | 12.42% | -41.1% | |
| ALKS | Sell | ALKERMES PLC | $112,877,000 | -41.9% | 2,659,676 | -43.6% | 8.99% | -61.8% |
| BIIB | Buy | BIOGEN INC | $104,072,000 | +28.3% | 294,564 | +5.4% | 8.29% | -15.8% |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $101,602,000 | +209.3% | 1,317,459 | +237.8% | 8.09% | +103.1% |
| EVFM | EVOFEM BIOSCIENCES INC | $38,852,000 | +49.4% | 9,593,197 | 0.0% | 3.09% | -1.8% | |
| NCNA | Buy | NUCANA PLCspon adr | $14,254,000 | +78.6% | 572,000 | +36.2% | 1.14% | +17.3% |
| NITE | Buy | NIGHTSTAR THERAPEUTICS PLCadr | $13,935,000 | +177.4% | 682,109 | +117.2% | 1.11% | +82.3% |
| MO | Exit | ALTRIA GROUP INC | $0 | – | -118,000 | -100.0% | -0.81% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2019-08-22
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| PROTHENA CORP PLC | 19 | Q2 2019 | 37.7% |
| ALKERMES PLC | 18 | Q1 2019 | 28.0% |
| THERAVANCE BIOPHARMA INC | 17 | Q3 2019 | 71.3% |
| BIOGEN INC | 12 | Q1 2019 | 9.8% |
| ABBVIE INC | 9 | Q3 2017 | 33.9% |
| NORTHWEST BIOTHERAPEUTICS INC | 9 | Q4 2016 | 12.7% |
| REYNOLDS AMERICAN INC | 7 | Q3 2016 | 45.9% |
| EVOFEM BIOSCIENCES INC | 7 | Q3 2019 | 20.3% |
| AUTOLUS THERAPEUTICS PLC | 6 | Q3 2019 | 33.9% |
| GILEAD SCIENCES INC | 6 | Q4 2017 | 7.6% |
View Woodford Investment Management Ltd's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Evofem Biosciences, Inc.Sold out | February 04, 2020 | 0 | 0.0% |
| Nightstar Therapeutics plcSold out | February 04, 2020 | 0 | 0.0% |
| Theravance Biopharma, Inc. | November 08, 2019 | 429,770 | 0.8% |
| Autolus Therapeutics plc | October 09, 2019 | 2,095,127 | 4.7% |
| NuCana plc | September 09, 2019 | 1,538,000 | 4.8% |
| Prothena Corp plcSold out | September 09, 2019 | 0 | 0.0% |
| NORTHWEST BIOTHERAPEUTICS INC | February 14, 2019 | 24,815,028 | 4.8% |
View Woodford Investment Management Ltd's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2020-02-04 |
| SC 13G/A | 2020-02-04 |
| 13F-HR | 2020-01-27 |
| 13F-HR/A | 2019-11-12 |
| 13F-HR | 2019-11-08 |
| SC 13G/A | 2019-11-08 |
| SC 13G/A | 2019-11-08 |
| SC 13G/A | 2019-10-09 |
| SC 13G/A | 2019-09-09 |
| SC 13G/A | 2019-09-09 |
View Woodford Investment Management Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.